logo

Akcea Therapeutics Inc. (AKCA)



Trade AKCA now with
  Date
  Headline
3/24/2020 7:07:51 AM Akcea Therapeutics Appoints Damien McDevitt As CEO
3/13/2020 7:07:30 AM Akcea Therapeutics Canada Celebrates Official Launch Of First-of-its-kind Research Grant Program
3/11/2020 7:23:23 AM Akcea Therapeutics Names Lisa Johnson-Pratt SVP Of New Product Strategy; Promotes Joshua Patterson To General Counsel
1/22/2020 7:09:37 AM Akcea And Ionis Announce Positive Topline Phase 2 Results Of AKCEA-APOCIII-L Rx
1/10/2020 7:02:55 AM Akcea And Ionis Begin CARDIO-TTRansform Phase 3 Clinical Trial For AKCEA-TTR-LRx
9/23/2019 7:11:01 AM Akcea Therapeutics Names Damien McDevitt Interim CEO; Michael Yang And Joseph ‘Skip’ Klein Join Board
11/29/2018 7:09:21 AM Akcea Therapeutics To Present Long-term Analyses Of NEURO-TTR Open-label Extension Study At ASH Annual Meeting
11/12/2018 6:57:41 AM Akcea : Phase 2 Results On AKCEA-APO-LRx Presented In Late-Breaking Clinical Trial Presentation
11/6/2018 7:19:14 AM Ionis Pharma Q3 Net Loss $5 Mln Vs. Net Loss $3 Mln Last Year
11/5/2018 4:12:13 PM Akcea Therapeutics Q3 EPS $0.73 Vs. Loss $0.33 Year Ago
10/10/2018 9:08:09 AM Ionis Announces New Collaboration With Roche To Develop IONIS-FB-LRx For Treatment Of Complement-mediated Diseases
10/8/2018 7:02:56 AM Akcea Therapeutics: Damien McDevitt Replaces Stanley Crooke On Board
  
 
>